Buscar
Mostrando ítems 1-10 de 151
Resultados del tratamiento con peginterferón alfa-2a y ribavirina en pacientes con hepatitis crónica C
(Sociedad Médica de Santiago, 2011)
Farmacovigilância no tratamento com peginterferon e ribavirina em pacientes com hepatite C crônica no serviço de hepatologia do Hospital Universitário de Aracaju-SEPHARMACOVIGILANCE IN THE TREATMENT WITH PEGINTERFERON AND RIBAVIRIN IN PATIENTS WITH CHRONIC HEPATITIS C IN THE SERVICE OF HEPATOLOGY AT UNIVERSITY HOSPITAL IN ARACAJU-SE.
(Universidade Federal de SergipePós-Graduação em Ciências da SaúdeBRUFS, 2017)
Peginterferon alfa-2a (40KD) (PEGASYS??) plus ribavirin (COPEGUS??) in retreatment of chronic hepatitis C patients, nonresponders and relapsers to previous conventional interferon plus ribavirin therapy
(The Brazilian Journal of Infectious Diseases and Contexto Publishing, 2006-02)
The results of a randomized trial looking at 24 weeks vs 48 weeks of treatment with peginterferon alpha-2a (40 kDa) and ribavirin combination therapy in patients with chronic hepatitis C genotype 1
(Blackwell Publishing, 2006-08-01)
Peginterferon-alpha plus ribavirin is the most effective therapy for chronic hepatitis C. This study was designed to evaluate the effect of peginterferon alpha-2a (40 kDa) plus ribavirin on sustained virological response ...
Eficacia comparativa del peginterferon alfa 2a más ribavirina vs. peginterferon alfa 2b más ribavirina en el tratamiento de infección crónica por el virus de la hepatitis C. Hospital Nacional Luis N. Sáenz PNP, años 2003-2010
(Universidad Nacional Mayor de San MarcosPE, 2011)
Determina diferencias en la eficacia del peginterferón alfa-2a más ribavirina en comparación con el peginterferón alfa-2b más ribavirina para el tratamiento de la infeccion crónica por virus de la Hepatitis C en el Hospital ...
Resultados del tratamiento de la hepatitis crónica por virus C en un hospital público, en Chile
(2012)
Background: Chronic hepatitis C is an important health problem in Chile. In
2005, the Ministry of Health started a pilot treatment program with peg interferon
and ribavirin, to be developed in public hospitals all over ...